Hong Kong · Delayed Price · Currency is HKD Alphamab Oncology Statistics
Total Valuation
HKG:9966 has a market cap or net worth of HKD 7.09 billion. The enterprise value is 5.72 billion.
| Market Cap | 7.09B |
| Enterprise Value | 5.72B |
Important Dates
The last earnings date was Wednesday, March 25, 2026.
| Earnings Date | Mar 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:9966 has 968.57 million shares outstanding. The number of shares has decreased by -2.32% in one year.
| Current Share Class | 968.57M |
| Shares Outstanding | 968.57M |
| Shares Change (YoY) | -2.32% |
| Shares Change (QoQ) | -2.26% |
| Owned by Insiders (%) | 50.12% |
| Owned by Institutions (%) | 3.37% |
| Float | 483.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.25 |
| PB Ratio | 3.72 |
| P/TBV Ratio | 3.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.67, with a Debt / Equity ratio of 0.07.
| Current Ratio | 5.67 |
| Quick Ratio | 5.29 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.80 |
| Interest Coverage | -20.58 |
Financial Efficiency
Return on equity (ROE) is -6.43% and return on invested capital (ROIC) is -4.97%.
| Return on Equity (ROE) | -6.43% |
| Return on Assets (ROA) | -4.42% |
| Return on Invested Capital (ROIC) | -4.97% |
| Return on Capital Employed (ROCE) | -8.44% |
| Weighted Average Cost of Capital (WACC) | 6.89% |
| Revenue Per Employee | 1.27M |
| Profits Per Employee | -254,603 |
| Employee Count | 498 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 0.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.70% in the last 52 weeks. The beta is 0.49, so HKG:9966's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -8.70% |
| 50-Day Moving Average | 9.31 |
| 200-Day Moving Average | 10.09 |
| Relative Strength Index (RSI) | 37.73 |
| Average Volume (20 Days) | 2,398,118 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:9966 had revenue of HKD 630.11 million and -126.79 million in losses. Loss per share was -0.13.
| Revenue | 630.11M |
| Gross Profit | 559.40M |
| Operating Income | -170.58M |
| Pretax Income | -126.79M |
| Net Income | -126.79M |
| EBITDA | -101.86M |
| EBIT | -170.58M |
| Loss Per Share | -0.13 |
Balance Sheet
The company has 1.50 billion in cash and 136.85 million in debt, with a net cash position of 1.37 billion or 1.41 per share.
| Cash & Cash Equivalents | 1.50B |
| Total Debt | 136.85M |
| Net Cash | 1.37B |
| Net Cash Per Share | 1.41 |
| Equity (Book Value) | 1.90B |
| Book Value Per Share | 1.97 |
| Working Capital | 1.46B |
Cash Flow
In the last 12 months, operating cash flow was -135.64 million and capital expenditures -35.15 million, giving a free cash flow of -170.79 million.
| Operating Cash Flow | -135.64M |
| Capital Expenditures | -35.15M |
| Depreciation & Amortization | 71.54M |
| Net Borrowing | -76.45M |
| Free Cash Flow | -170.79M |
| FCF Per Share | -0.18 |
Margins
Gross margin is 88.78%, with operating and profit margins of -27.07% and -20.12%.
| Gross Margin | 88.78% |
| Operating Margin | -27.07% |
| Pretax Margin | -20.12% |
| Profit Margin | -20.12% |
| EBITDA Margin | -16.17% |
| EBIT Margin | -27.07% |
| FCF Margin | n/a |
Dividends & Yields
HKG:9966 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.32% |
| Shareholder Yield | 2.32% |
| Earnings Yield | -1.79% |
| FCF Yield | -2.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for HKG:9966 is 9.82, which is 34.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 9.82 |
| Price Target Difference | 34.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | 23.90% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:9966 has an Altman Z-Score of 10.71 and a Piotroski F-Score of 2.
| Altman Z-Score | 10.71 |
| Piotroski F-Score | 2 |